LEX-WK-2DQHGWBTcrawled 2018-07-30 09:32Z
New Guidance Makes Clear that FDA Is Focused on Insanitary Conditions at Pharmacy Compounders
Robert Church · Jim Johnson · Christopher Fanelli · Focus on Regulation · Published August 3, 2016
Work details
- author
- Robert Church · Jim Johnson · Christopher Fanelli
- firm or organization
- Hogan Lovells
- publication
- Focus on Regulation
- practice area
- Health Care and Life Sciences
- published
- 2016-08-03
Citation
Robert Church, Jim Johnson, Christopher Fanelli, New Guidance Makes Clear that FDA Is Focused on Insanitary Conditions at Pharmacy Compounders, Focus on Regulation (August 3, 2016) [The Library at LexBlog, LEX-WK-2DQHGWBT, lexpid.org/2DQHGWBT]